CURRICULUM VITAE - ohsu.edu€¦ · Web viewColumbia University, Political Science (Political Theory) 1995M. Phil. Columbia University, Political Science (Political Theory)

CURRICULUM VITAE

NAME Lynn A. Jansen, RN, PhD DATE February 3, 2016

PRESENT POSITION AND ADDRESS

Academic Rank: Madeline Brill Nelson Chair in Ethics Education &Associate Professor

Department / Division: Internal Medicine, Geriatrics/Ethics

Professional Address:

The Center for Ethics in Health CareOregon Health & Science University3181 S.W, Sam Jackson Park, Rd (UHN-86)Portland, Oregon 97238

E-Mail Address: [email protected]

I. EDUCATION

Undergraduate and Graduate (Include Year, Degree, and Institution):

1997 Ph.D. Columbia University, Political Science (Political Theory) 1995 M. Phil. Columbia University, Political Science (Political Theory)1991 MA. Columbia University, Political Science (Political Theory)1989 BA. Nova Southeastern University, Political and Legal Studies1987 AS. Broward Community College, Nursing (RN)

Postgraduate (Include Year, Degree, and Institution):

2000 Ethics Fellow University of Chicago MacLean Center for Clinical Medical Ethics.

Licenses (Include State, Date, Status, Number, and Renewal Date):

Registered Professional Nurse

II. PROFFESIONAL EXPERIENCE

Lynn A. Jansen, RN, PhD

Academic (Include Year, Position, and Institution):

2010-present Madeline Brill Nelson Chair in Ethics Education, The Center for Ethics in Health Care, Oregon Health & Science University, Portland, OR

2010-present Member of Knight’s Cancer Prevention and Control Program, Knight Cancer Institute, Oregon Health & Science University, Portland, OR

2010-present Associate Professor, Department of Internal Medicine & Geriatrics, Oregon Health &Science University, Portland Oregon

2006-2010 Associate Research Professor of Medicine, Department of Medicine, New York Medical College, Valhalla, NY

2000-2006 Assistant Research Professor of Medicine, Department of Medicine, New York Medical College, Valhalla, NY

1999-2000 Fellow, MacLean Center for Medical Ethics University of Chicago, Chicago, IL1996 Adjunct Assistant Professor, Department of Political Science, Dowling College,

Long Island, NY1992-1994 Preceptor, Department of Political Science, Columbia University, New York, NY

Administrative (Include Year, Position, and Institution):

2010-Present Associate Director, The Center for Ethics in Health Care, Oregon Health & Science University, Portland, OR

2010-2010 Executive Director, The Bioethics Institute, New York Medical College, Valhalla, NY

Oct. 2009 Executive Director and Chair, The John J. Conley Center for Ethics, St. Vincent’s Hospital, NY

May 2009-Oct 2009 Acting Chair, John J. Conley Department of Ethics, St. Vincent’s Hospital, NY2000-2010 Assistant Director, The Bioethics Institute, New York Medical College, Valhalla,

NY

III. SCHOLARSHIP

Area(s) of Research/Scholarly Interest:

Clinical EthicsResearch EthicsEthics Education

Grants and Contracts:

Federal (Include Title, Source, PI, Amount, Period)

January 2015-January 2016 Principal Investigator, Lynn A. Jansen, “The Normative Significance of the Optimistic Bias for Informed Consent toClinical Research,” Greenwall Foundation. $59,125.00

July 2012- May 2017 Principal Investigator, Lynn A. Jansen “Understanding

CV 03/22/17 Lynn A. Jansen, RN, PhD 2

Therapeutic Optimism and its Impact on Risk/Benefit Assessment,” NIH-NCI GRANT #1 R01CA166556. $1,200,000

July 2008-June, 2011 Principal Investigator, Lynn A. Jansen “Understanding Optimism in Clinical Research,” NIH-NCI GRANT #1 R21 CA131601. $250,000

Peer-Reviewed Publications:

Books:

1) Jansen, Lynn A. (2006) Death in the Clinic. Landham, Md. Rowman & Littlefield.

Articles:

1) Jansen, Lynn A. “Assessing Clinical Pragmatism,” Kennedy Institute of Ethics Journal (March, 1998) Vol.8, No.1:25-36.

2) Jansen, Lynn A. and Lainie Friedman Ross, “Patient Confidentiality and the Surrogate’s Right to Know,” Journal of Law, Medicine and Ethics (Summer, 2000) Vol. 28, No. 2:125-137.

3) Jansen, Lynn A. “The Virtues in their Place: Virtue Ethics and Medicine,” Theoretical Medicine and Bioethics (October, 2000) Vol.21, No.8:261-276.

4) Jansen, Lynn A. “Deliberative Decision Making and the Treatment of Pain,” Journal of Palliative Medicine (Spring, 2001) Vol. 4, Number 1: 23-31.

5) Jansen, Lynn A and Lainie Friedman Ross, “The Ethics of Pre-Adoption Genetic Testing,” The American Journal of Medical Genetics (October, 2001) Vol. 104: 214-220.

6) Lebovits, A.H., Zenetos, P., O’Neill, D.K., Cox, D., Dubois, M.Y., Jansen, L.A. and Turndorf, H. “Satisfaction with epidural and intravenous patient controlled analgesia.” Pain Medicine 2: (2001).

7) Jansen, Lynn A. “Ethical Concerns about the Detection and Treatment of Ovarian Cancer,” Gynecologic Oncology, (2002) Vol. 84: 1-3.

8) Jansen, Lynn A. “Evil, Forgiveness and the Moral Community,” National Catholic Bioethics Quarterly (Spring, 2002) 21-25. *Received Honorable Mention for best scholarly article from National Catholic Bioethics Quarterly.

9) Jansen, Lynn A. and Daniel P. Sulmasy. “Sedation, Alimentation and Equivocation: Careful Conversation about Care at the End of Life.” The Annals of Internal Medicine (June 4, 2002) Vol. 136: 845-849.

10) Jansen, Lynn A. and Daniel P. Sulmasy. “Proportionality, Suffering and The Restorative Goals of Medicine,” Theoretical Medicine and Bioethics (2002) Vol. 23: 321-337.


11) Jansen, Lynn A. “The Moral Irrelevance of Proximity to Death.” Journal of Clinical Ethics (2003) 14: 49-58.

12) Jansen, Lynn A. and Daniel P. Sulmasy. “Bioethics, Conflicts of Interest and The Limits of Transparency,” The Hastings Center Report. (July-August, 2003) 33: 40-43.

13) Jansen, Lynn A. “Child Organ Donation, Family Autonomy and Intimate Attachments.” Cambridge Quarterly of Healthcare Ethics, 13 (2004) 133-141. *Reprinted in Bioethics in a Changing World, eds. Jennifer Parks and Victoria Wilkes. (Prentice Hall, 2009). 14) Jansen, Lynn A. “No Safe Harbor: The Problem of Complicity and the Practice of Voluntary Stopping of Eating and Drinking,” The Journal of Medicine and Philosophy, 29 (Feb 2004) 61-75. *Reprinted in Current Controversies: Suicide, ed. Paul Connors. (Greenhaven Press, 2007).

15) Jansen, Lynn A. “On Self-Determination, Care by Proxy, and New Techniques,” Pain Medicine (March, 2004) 5: 94-95.

16) Jansen, Lynn A. “Ethical and Legal Considerations in Adoption Referral for Physicians.” American College of Physicians PIER Module. (April, 2004) available on line at: http://pier.acponline.org

17) Jansen, Lynn A. “HIV Exceptionalism, CD4+ Cell Testing, and Conscientious Subversion,” Journal of Medical Ethics (June 2005) 31: 322-326.

18) Jansen, Lynn A. “Local IRBs, Multi-Center Trials, and The Ethics of Internal Amendments," IRB: Ethics and Human Research (July –August, 2005) 7-11.

19) Jansen, Lynn A. “A Closer Look at The Bad Deal Trial: Beyond Clinical Equipoise.” The Hastings Center Report (2005) Vol. 35, No.5:29-36.

20) Jansen, Lynn A. “Hastening Death and the Boundaries of the Self.” Bioethics (2006) Vol. 20, No.2:105-111.

21) Jansen, Lynn A. “The Problem with Optimism in Clinical Trials," IRB: Ethics and Human Research (July-August, 2006) 13-19.

22) Jansen, Lynn A. and Steven Wall, “Paternalism and Fairness in Clinical Research,” Bioethics (March, 2009) 172-182.

23) Jansen, Lynn A. “Consensus and Independent Judgment: Or What Can an 18TH Century Mathematician Teach Us About Ethics Consultation,” The Journal of Clinical Ethics (Spring, 2009) Vol. 20:56-63.

24) Jansen, Lynn A. “The Ethics of Altruism in Clinical Research,” The Hastings Center Report (July-August 2009) Vol. 39:26-36. *With a response/comment by Nancy M.P.King “Benefits, Harms, and Motives in Clinical Research.”

25) Jansen, Lynn A. “Disambiguating Clinical Intentions: The Ethics of Palliative Sedation,” The


http://pier.acponline.org/

Journal of Medicine and Philosophy (January, 2010):1-13.

26) Jansen, Lynn A. and Jessica S. Fogel. “Ascribing Intentions in Clinical Decision-Making,” Journal of Medical Ethics (January, 2010):2-6.

27) Jansen, Lynn A. Appelbaum Paul, Klein William MP, Weinstein, Neil D, Cook William, Fogel Jessica S, Sulmasy, Daniel P. “Unrealistic Optimism in Early Phase Oncology Trials,” IRB: Ethics and Human Research, (January-February, 2011):1-8.**Article received national media attention. Reported on in The New York Times, The Wall Street Journal, MSNBC, The LA Times, and JAMA and ASCO Post.

28) Jansen, Lynn A. “Two Concepts of Therapeutic Optimism,” The Journal of Medical Ethics 2011;37:563-566.

29) Jansen, Lynn A. “Consent, Exploitation, and Autonomy in Clinical Research,” in Theoretical and Applied Ethics (Spring, 2011):32-34.

30) Jansen, Lynn A., Jessica S. Fogel and Mark Brubaker. “Experimental Philosophy, Clinical Intentions and Evaluative Judgment,” Cambridge Quarterly Journal of Health Care Ethics (2013), 22, 1-10.

31) Jansen, Lynn A. “Between Beneficence and Justice: The Ethics of Stewardship in Medicine," The Journal of Medicine and Philosophy (January, 2013) 38;1:50-63.

32) Jansen, Lynn A. "Stewardship." Bioethics. Ed. Bruce Jennings. 4th ed. Vol. 6. Farmington Hills, MI: Macmillan Reference USA, 2014. 3011-3016. (Gale Virtual Reference Library. Web. 25 June 2014 Encyclopedia of Bioethics.)

33) Jansen, Lynn A and Steven Wall. “Rethinking Exploitation: A Process-Centered Account,” Kennedy Institute of Ethics Journal 23(4) 2013:381-410.

34) Jansen, Lynn A. “Mindsets, Informed Consent and Research,” The Hastings Center Report 44(2014);25-32. *With responses from Paul Appelbaum, Charles Lidtz, Steven Joffe and Jennifer W. Mack.

35) Jansen, Lynn A. and Eran Klein. “Consent Through Rose-Tinted glasses: The Optimistic Bias in Parkinson’s Disease Clinical Trials,” American Journal of Bioethics/Neuroscience. 6 (1):1-3, (2015).

36) Jansen, Lynn A. "The Optimistic Bias and Illusions of Control in Clinical Research," IRB: Ethics and Human Research. March/April, 2016.

37) Jansen, Lynn A. “Taking Respect Seriously: Clinical Research and the Demands of Informed Consent,” The Journal of Medicine and Philosophy, October, 2016 (In press).

38) Jansen, Lynn A. Daruka Mahadevan, Paul S. Appelbaum, et al. “Dispositional Optimism and Therapeutic Expectations in Early Phase Oncology Trials,” Cancer Feb 2016 (DOI: 10.1002/cncr.29908).

39) Jansen, Lynn A., Daruka Mahadevan, Paul S. Appelbaum, et al. “The Impact of Unrealistic Optimism on Informed Consent to Participate in Early Phase Oncology Trials,” IRB: Ethics and Human Research. 2016;38(5):1-7.


40) Jansen, Lynn A. and Steven Wall. “Reconsidering Paternalism in Clinical Research,” Bioethics. (Conditionally accepted; October 2016).

41) Cassel, Brian J., Egidio Del Fabbro, MD, Tobias Arkenau, Irene J. Higginson, Samia Hurst, Lynn A. Jansen, Andrew Poklepovic, Annette Rid, Jordi Rodon, Florian Strasser, Franklin G. Miller, "Phase I cancer trials and palliative care: Antagonism, irrelevance, or synergy?," Journal of Pain and Symptom Management. May 24, 2016 (doi:10.1016/j.jpainsympman.2016.02014).

42) Jansen, Lynn A., Paul S. Appelbaum, Klein William et al. “Perceptions of Control and Unrealistic Optimism in Early Phase Cancer Trials,” (under review).

43) Jansen, Lynn A., Paul S. Appelbaum, Klein William et al. “Variations in Unrealistic Optimism between Acceptors and Decliners of Early Phase Cancer Trials,” (under review)

Invited Commentaries/Editorials:

1) Jansen, Lynn A. “Physician vs. Scientist?” The Hastings Center Report (March-April, 2008): 3.

2) Jansen, Lynn A. “Intractable End-of Life Suffering and the Ethics of Palliative Sedation: A Commentary on Cassell and Rich,” Pain Medicine (March, 2010) Vol. 11:440-441. *With a response/comment by Eric J. Cassell and Ben J. Rich, “Responses to Commentaries by Jansen and Banja.”

3) Jansen Lynn A. “Voluntary Stopping of Eating and Drinking (VSED), Physician-Assisted Suicide (PAS), or Neither in the Last Stage of Life? PAS: No; VSED: It Depends” Ann Fam Med September/October (2015) 13:410-41.

Book Chapters:

1) Jansen, Lynn A. “The Role of The Nurse in Clinical Genetics,” in Genetics in the Clinic: Clinical, Ethical and Social Implications for Primary Care. Edited by: Mary B. Mahowald, Victor McKusick Angela Scheuerle and Timothy Aspinwall (New York: Mosby Inc., 2001), pp. 133-142.

2) Jansen, Lynn A. "The Ethics of Case Management in the Context of Managed Care" in A CaseManagers Survival Guide. Edited by: T. Cesta et al. (New York: Mosby Inc., 2002) pp. 324-335.

3) Jansen, Lynn A., Barbara Johnston and Daniel P. Sulmasy. “AIDS and the Ethics of Palliative Care” in A Clinical Guide on Supportive and Palliative Care for People with HIV. Edited by: Joseph O’Neill. (Rockville, MD: Health Resources and Administration, 2003), chapter 17.

4) Jansen, Lynn A. “Ethics Consultation at the End-of-life: Ideals, Rules, and Standards to Guide Decision-Making,” in Ethics By Committee: A Textbook on Consultation, Organization, and Hospital Ethics Committees. Edited by: D. Micah Hester (Rowman and Littlefield, 2007), pp. 161-186.

Book Reviews:


1) Jansen, Lynn A. Review of Natural Law and Moral Inquiry: Ethics, Metaphysics and Politics in the Work of Germain Grisez, Edited by: Robert P. George. Catholic Bioethics Quarterly (Summer, 2001).

2) Jansen, Lynn A. Review of Patient-Centered Ethics and Communication at the End of Life, David Jeffrey (Oxford: Radcliffe Publishing, 2006). HIV Nursing May, 2006.

3) Jansen, Lynn A. Review of The Stem Cell Divide: The Facts, The Fictions, and The Fear Driving The Greatest Scientific, Political, and Religious Debate of Our Time, Micheal Bellomo (AMACOM Press, 2006).

4) Jansen, Lynn A. “Struggling with the Dilemma of Exploitation in the Developing World”, IRB: Ethics and Human Research July-August, 2009.

Letters:

1) Jansen, Lynn A. “Response to Peter Riga,” The National Catholic Bioethics Quarterly (Summer, 2002).

2) Jansen, Lynn A. and DP. Sulmasy, “Response to Replies on Sedation, Alimentation and Equivocation: Careful Conversation about Care at the End of Life.” The Annals of Internal Medicine (December 17, 2002).

3) Astrow, Alan B. and Lynn A. Jansen. “Spirituality, Religion, and Medical Care: A Response to Neil E. Scheurich,” Academic Medicine (June 16, 2003).

4) Jansen, Lynn A. and DP Sulmasy. “Response to Replies on “Bioethics, Conflicts of Interest and The Limits of Transparency,” The Hastings Center Report (December, 2003).

5) Jansen, Lynn A. “Responses to Replies on “A Closer Look at The Bad Deal Trial: Beyond Clinical Equipoise,” in The Hastings Center Report (January-February, 2006).

Abstracts:

1) Sulmasy, DP, Jansen, LA, Ury WA. “Might Futility Determinations Relieve Surrogates of an Unnecessary Burden?” Journal of General Internal Medicine (April, supp. 2001) Vol. 16: 233.

2) Jansen, Lynn A and DP Sulmasy, “Terminal sedation: conceptual clarifications and moral controversies.” Journal of General Internal Medicine 2002; 17 (supp 1):173. Accepted for presentation, Society of General Internal Medicine Annual Meeting, Atlanta, GA (May, 2002).

3) Jansen, Lynn A. “Deliberation and Bioethics,” Genetics in Medicine (May/June, 2003).

Major National Media Attention/Coverage of Work:

1) The New York Times (March 3, 2011) “When Optimism is Unrealistic,” by, Pauline W. Chen. 2) JAMA (March 23/30, 2011- Vol. 305:1186-1187) “Patients’ Unrealistic Hopes for Cancer Trial

Benefits MAY Hinder Consent,” by Bridget M. Kuehn.3) The Wall Street Journal (January 29, 2011) “Too Optimistic to Consent?” by Christopher Shea.


4) WSJ Blogs: Ideas Market.(January 28, 2011) False Hope? By Christopher Shea.5) Los Angeles Times (January 25, 2011) “Unrealistic Optimism: A Problem in Clinical Trials of Cancer

Drugs,” by Karen Kaplan.6) Medpage Today (January 27, 2011) “Cancer Trial Patients Take Rosy View of Likely Benefit Science

News,” by John Gever.7) Science News (January 24, 2011) “Unrealistic Optimism Appears Common in Early Cancer Trials

and May Compromise Informed Consent.”8) e! Science News (January 24, 2011) “Unrealistic Optimism appears common in early phase oncology

trials.”9) Health News (January 27, 2011) “Are Some CANCER patients Involved in Clinical Trials Too

Optimistic? Why?”10) Medical News Today (January 25, 2011) “Informed Consent May be Compromised by Unrealistic

Optimism in Early Cancer Trials.”11) ASCO (American Society of Clinical Oncology) interview September 1, 2011- by Jo Cavello.12) Portland Tribune “A Pill to Cure All Ills? It’s Just in Our Heads,” July 5, 2012- by Peter Korn.13) IRB Advisor “Optimism bias may subvert informed consent in early phase cancer trials” May 2016

(pp.58-59) by Gary Evans.

Invited Lectures, Conference Presentations or Professorships:

International and National:

April 8, 2000. “The Economics of Race and Gender Differentials in Medicine,” Oak Forest Hospital, Oak Forest, Illinois.

May, 2000 “Collaboration and the Limits of Publicity in Medicine: A Response to Christopher Crenner’s Essay on Richard Cabot." American Society of Internal Medicine Conference, Boston, MA.

October, 2001 “Terminal Suffering: Classifications, Problems and Clinical Implications.” American Society of Bioethics and Humanities Conference. Nashville, TN.

March 13, 2003 “Deliberative Decision-Making and Genetic Counseling,” Plenary session for the American College of Medical Genetics, San Diego, CA.

October, 2003 “Professional Integrity and The Contexts of Disclosure.” American Society of Bioethics and Humanities Conference and the Canadian Bioethics Society, Montreal, Canada.

March, 2004 “Ethics Charter for Pain Medicine” American Academy of Pain Medicine. Drafted with 13 other co-authors, Chicago, IL.

October, 2007 Consensus and Independent Judgment: Or, What Can an 18th Century Mathematician Teach Us About Ethics Consultation,” The MacLean Center of Clinical Ethics Conference, Chicago IL.

February, 2008 “Ethics Consultation at the End-of-Life,” Association for Practical and Professional Ethics, Austin, TX.


April 12, 2010 “The Nature and Moral Significance of Consciousness,” Conference on Music Therapy and Disorders of Consciousness, New York, NY.

May 11, 2010 “The Problem with Optimism in Clinical Research,” Columbia University Department of Psychiatry Grand Rounds, New York, NY.

May 27, 2010 “Therapeutic Optimism and Informed Consent in Clinical Research,” Maxim Brettler Distinguished Lecture on Medical Humanities, North Shore Hospital, Long Island, NY.

June 3, 2010 “The Problem with Optimism in Clinical Research,” Madeline Brill Nelson Lecture Series in Ethics Education, Oregon Health and Science University, Portland, OR.

April 15, 2011 “The Culture of Hope and Informed Consent,” The 21st Annual Kinsman Conference, Eugene Oregon.

November 12, 2011 “The Problem with Optimism and Clinical Trials,” The 23rd Annual Dorothy J. MacLean Fellows Conference,” The University of Chicago, Chicago, Illinois.

April 19, 2012 “Stewardship in Medicine: What are we talking about?” Plenary Speaker, 22nd

Annual Kinsman Conference on Medical Ethics. Portland Oregon.

May 5, 2012 “Ethical issues in human bioenhancement: Replies to Allen Buchanan,” University of Arizona Department of Philosophy.

October 19, 2012 “Exploitation and Reasonable Parity in International Clinical Research: Replies to Vida Panitch” Faculty Mentor, American Society of Bioethics and Humanities, Washington DC.

April 12, 2013 “Promoting individual health and well-being through the use of biomedical enhancements,” 23nd Annual Kinsman Conference on Medical Ethics. Ashland Oregon.

November 15, 2013 ‘The Complexity of Clinical Intentions,” 25th Anniversary Dorothy J. MacLean Fellows Conference on Clinical Medical Ethics. University of Chicago.

July 15-16, 2014 "Recent Developments in Phase I Oncology Trials: Implications for ethics, palliative care, and society," The Brocher Foundation, Geneva, Switzerland.

October 23 2014 “The Optimistic Bias and High Quality Informed Consent in Research,” Conference co-sponsored by OHRP and Children’s Hospital of Philadelphia, in Philadelphia.

November 14, 2014 “Perceived Controllability and the Therapeutic Error in Research,” MacLean

Center- University of Chicago.

May 15, 2015 “General Beneficence and Professional Associations,” 25 th Annual Kinsman Conference on Medical Ethics. Portland, Oregon.


November 14, 2015 “Risk/Benefit Assessment, Unrealistic Optimism and Informed Consent,” Plenary Panel talk at PRIM-R’s AER Conference (Public Responsibility in Medicine and Research). Boston, Mass.

November 12, 2016 ‘Unrealistic Optimism and the Mindset Hypothesis’ 27 th Anniversary Dorothy J. MacLean Fellows Conference on Clinical Medical Ethics. University of Chicago Maclean Conference.

February 7, 2017 “Optimism, Informed Consent and the Mindset Hypothesis” Department of

Philosophy, University of Oregon.

Local:

December 8, 2010 “The Ethics of Hope and Truth- Telling,” Bioethics Study Group, Oregon Health and Science University.

March 2, 2011 “What to tell participants in clinical trials: Is consent informed?” Oregon Health & Science University, OCTRI Human Investigators Research Lecture Series.

May 19, 2011 “Understanding Optimism in Clinical Research,” Oregon Health & Science University, School of Nursing Research Scholar Lecture Series.

September 6, 2011 “Unrealistic Optimism in Early Phase Oncology Trials,” Grand Rounds, Oregon Health & Science University, School of Medicine.

May 7, 2012 “Unrealistic Optimism in Early Phase Oncology Trials,” Grand Rounds, Oregon Health & Science University, Department of Social Work.

October 17, 2012 “How should we interpret patients' understandings of risks and benefits in clinic research,” Grand Rounds, Oregon Health & Science University, Center for Hematologic Malignancies.

November 15, 2012 “Raising the bar in ethics and interprofessionalism,” Grand Rounds, Oregon Health & Science University.

May 15, 2013 “Some ethical concerns about optimism in the clinic and in research,” Keynote Speaker. Sigma Theta Tau Induction Ceremony, Oregon Health & Science University.

December 10. 2013 “Therapeutic Misconception and Unrealistic Optimism in Clinical Research,” Invited lecture to Masters in Clinical Research Students. Oregon Health & Science University.

December 10, 2014 “Optimism and Consent in Clinical Research,” Invited lecture to Masters in Clinical Research Students. Oregon Health & Science University.

December 8, 2015 “Risk/Benefit Assessment, Optimism and Informed Consent,” Invited lecture to Masters in Clinical Research Students. Oregon Health & Science University.


February 11, 2016 "Ethical Issues in Human Subjects Research: Insights from Social Psychology,” Grand Rounds for the Department of Psychiatry, Oregon Health & Science University.

April 15, 2016 “Synthesizing a Keynote Address: What is the Future of Clinical Ethics in Health Care,” (panel moderator), The Statewide Kinsman Conference in Bioethics, Hood River, Oregon.

May 11, 2016 “Optimism and Informed Consent: Insights from Social Psychology,” Bioethics Study Group, Oregon Health & Science University, Portland, Oregon.

November 14, 2016 “How to Analyze an Ethics Case: A Brief Introduction” Oregon Health & Science University, School of Nursing, Portland, Oregon.

November 22, 2016 “Clinical Research, Informed Consent and the Mindset Hypothesis” Department of Medicine Grand Rounds, Oregon Health & Science University, Portland Oregon.

December 14, 2016 “Unrealistic Optimism and the Mindset Hypothesis,” Invited lecture for Masters in Clinical Research, Oregon Health & Science University.

March 9, 2017 “Introduction to Ethical Reasoning” Oregon Health & Science University, School of Nursing, Portland, Oregon.

IV. SERVICE

Membership in Professional Societies:

1) American Academy of Pain Medicine, Chicago (2003-2004).

2) American Association of Bioethics and Humanities (2000-2002).

Granting Agency Review Work:

1) NIH- peer review for NIH Study Section on Societal and Ethical Issues in Research “Revision applications to advance evidence-based research related to protections for human subjects,” working with Karin Helmers, PhD (SRO) July-August, 2012. ZRG1 HDM-B90.

2) NIH-peer review for Jennifer Schiltz, PhD (SRO) (NIH/NCI) June 28-29, 2016 ZCA1 SRB-5 (O1) NCI Omnibus R03.

Editorial and Ad Hoc Review Activities:

1) 2010-present: Associate Editor. Theoretical Medicine and Bioethics.


2) 2002-2010: Co-Editor. Theoretical Medicine and Bioethics.

3) 2002-present: Manuscript Reviewer

Kennedy Institute of Ethics Journal The Hastings Center Report Journal of Clinical Ethics The Journal of Medical Ethics Pain Medicine Annals of Internal Medicine Journal of Palliative Care IRB: Ethics & Human Research Bioethics Theoretical Medicine & Bioethics Clinical Trials American Journal of BioethicsBritish Journal of Cancer

Committees:

International/National:

1) Advisory Panel Member: “Science and the Ethics of Enhancement,” National Public Broadcasting Service. The Fred Friendly Seminar, NY (May, 2006).

2) Member: Council on Ethics, American Academy of Pain Medicine, Chicago (2003-2010).

Regional:

1) Ethics Advisory Council: The National Ovarian Cancer Coalition, Westchester Division (2001-2005).

2) Member: Health Care Ethics Committee, The New York Foundling Hospital, NY (2000-2010).

3) Co-Chair: The Annual Kinsman Conference Planning Committee, Portland Oregon (2010-Present).

Institutional:

1) Member: Integrated Scientific and Ethical Review Board (ISERB): St Vincent’s Hospital, NY (2005-2010).

2) Member: Health Care Ethics Committee, St. Vincent’s Hospital, NY (2000-2010).

3) Co-Chair: Teaching Interprofessional Ethics: (with Phyllis Beemsterboer, Ed.D) Oregon Health and Science University (2010-2016).

4) Member: Ethics Consultation Committee, Oregon Health & Science University (2010-present).


5) Member, OHSU Institutional Ethics Committee, Oregon Health & Science University (2010-present).

Departmental:

1) Member: First and Second Year Medical Education Curriculum Development Committee, New York Medical College, NY (2000-2010).

2) Course Director: First and Second Year Medical Ethics, New York Medical College, NY (2000-2010).

3) Member: Executive Committee for the Center for Ethics in Health Care, Oregon Health & Science University, (2010-present).

4) Ethics Course Director for Principles of Clinical Medicine, Oregon Health & Science University, 2010-2014).

5) Ethics Course Director for Transition to Residency, Oregon Health & Science University, 2010-2015).

6) Ethics Course Director for Medical School Pain Intersession, Oregon Health & Science University (2015-)

Clinical Responsibilities:

2010: Medical Ethics Consultant, Archdiocese for the City of New York.2000-2010: Senior Medical Ethicist, St. Vincent’s Hospital, NY2001-2005: Med/Surgical RN, St. Joseph’s Medical Center, Yonkers, NY1999-2000: Clinical Ethics Consultant, Oak Forest Hospital. Il.1996-1999: Pain Management RN, NYU Medical Center, NY1992-1995: Critical Care RN, St. Luke’s/Roosevelt Hospital, NY1989-1992: Med/Surgical RN, St. Luke’s/Roosevelt Hospital, NY1987-1989: Neurology RN, Cedar’s Medical Center, FL.1986-1987 Oncology RN, Imperial Point Medical Center, FL

V. TEACHING

2016- Content developer for ethics sessions in the School of Medicine’s “Pain Inter-session course.”Oregon Health & Science University. Second year medical students. 6 sessions per year, Each session 3 hours long.

2015 Interprofessional Education-Oregon Health & Science University. Small group facilitator for four IPE sessions attended by medical, nursing pharmacy PA and dietician students. Each session 4 hours long.

December, 2014 Ethics faculty member for panel on “Pre-implantation Genetic Diagnosis: a deeper dive.” Oregon Health and Science University. First year medical students. Small group facilitator for three 4 hour sessions.


2014- present Ethics curriculum development for new medical school curriculum. Oregon Health and Science University. Created interactive small group ethics modules for first year medical students to fit into the ‘new curriculum at the school of medicine. Ten sessions/ one hour and fifty minutes per session.

2014- 2015 Interprofessional Ethics. Oregon Health and Science University. Schools of Nursing, Medicine, Pharmacy, Dentistry and PA. Facilitator for small group discussions. Three sessions per year/four hours each session.

March 9, 2012 “Interprofessional Collaboration: A Dynamic Model for Contemporary Practice.” Oregon Health and Science University. Schools of Nursing, Medicine, Pharmacy, Dentistry and PA. Assisted Steering Committee in the development of the ethics portion of the curriculum, organized 4 hour interprofessional ethics session, and facilitated small group.

April, 2012 Pharmacy Ethics Interest Group: Oregon Health and Science University. four hour long teaching sessions for graduate pharmacy students. Assisted in organizing course content and facilitating small group discussions.

2010-2013 Principles of Clinical Medicine (Ethics Component); Oregon Health and Science University. Responsibilities: curriculum development, teaching and course direction for small group faculty facilitators. Eight sessions/two hours each session.

2010-2017 Transition to Residency (Ethics Component): Oregon Health and Science University. Responsibilities: curriculum development, teaching and course direction for small group faculty facilitators. Four hours teaching once a year.

2010- 2016 Interprofessional Ethics Fellowship; Oregon Health & Science University. Responsibilities: provide lectures, evaluate and grade fellow essays, mentor second year fellow in research project. 4 sessions/ two hours each session.

2010-2013 Teaching Interprofessional Ethics: Oregon Health & Science University. Responsibilities: develop interprofessional ethics curriculum, provide leadership for faculty participants from schools of nursing, medicine, dentistry, and pharmacy.

2010-present Teaching Dental Ethics: Oregon Health & Science University (School of Dentistry). Responsibilities: Small group faculty facilitator. Six sessions/one hour each session.

2000-2010 First Year Bioethics : New York Medical College (Course numbers 1101-1102) 15 hours/year. Responsibilities: curriculum development, course direction for 18 small group faculty facilitators, two formal 45 minute large group lectures and small group facilitator for 10 sessions.

2000-2010 Second Year Bioethics: New York Medical College: (Course number 2101)7.5 hrs/year. Responsibilities: curriculum development, lecture, course

direction.


2008-2010 Research Ethics for graduate students in the Basic Sciences. 2hrs/year.Responsibilities: lecture and small group facilitator.

Service and Membership of Educational Committees:

2010-2016: Co-Chair “Teaching Interprofessional Ethics Committee.” Interprofessional group of faculty leaders at Oregon Health & Science University who work together to create an innovative ethics curriculum that can be used to teach ethics and professionalism to students in all of the health care professions at Oregon Health & Science University.

Professional Development in Education:

2010-present- Co-Chair “Bioethics Study Group.” Co-lead a group of faculty members in arranging ten one hour faculty development sessions in medical ethics for faculty at Oregon Health &Science University and the community.

VI. CONFERENCE PLANNING

2010-Present Co-Chair : “The 23rd Annual Kinsman Conference,” Portland, Oregon.2010-Present Co-Chair: “The Daniel Labby Senior Clinicians Seminar,” OHSU Center for Ethics in Health Care.

VII. MENTORING AND ADVISING

Mentoring responsibilities included: discussion/tutorial on selected readings, guidance on conducting and writing up clinical ethics consultations, and assistance with research projects. Additional time was spent in helping to prepare manuscripts for publication.

2006 Faculty mentor to third year medical student’s clinical ethics elective

2009 Faculty mentor to Mark Brubaker (MD/Resident)

2010-2011 Faculty advisor to Daniel Kennedy, D.PH (school of pharmacy)

2011-2012 Faculty mentor to Denise Mathes, RN, MPH (ethics fellowship)

2012-2013 Faculty mentor to Donna Kim, MD (ethics fellowship)

2012 Faculty mentor to Vida Panitch, PhD American Society of Bioethics and Humanities, Washington DC. October 19-20, 2012.

2014-15 Faculty collaborator with Eran Klein, MD, PhD (Senior Scholar at Center for Ethics in Health Care).


2015 Faculty advisor to Andy Harris, MD –Provided guidance on ethics curriculum development for course global health ethics.

2015 Faculty advisor to Paul Gorman, MD-Provided materials and guidance on curriculum related to the ethics of stewardship for first year medical students.

2016 Faculty advisor to Amy Vandenbrouke, JD- Provided materials and guidance on curriculum development for ethics in radiology.

2016 Faculty mentor to Berklee Robins, MD- Reviewed and provided comments on revising Master’s degree in Ethics thesis into a publishable manuscript.

2016 Faculty mentor to Laurel Foran, MD student thesis on ethics.


Documents

CURRICULUM VITAE - ohsu.edu€¦ · Web viewColumbia University, Political Science (Political Theory) 1995M. Phil. Columbia University, Political Science (Political Theory)